News
1 - 2 of 2 news items
-
Reassessment of reimbursement status for 5 combination products in ATC groups C07, C08 and C09
| 27 November 2008 |
The Danish Medicines Agency has assessed the question of the future reimbursement status for five combination products in ATC groups C07, C08 and C09 on the basis of updated information about prices and consumption of these medicinal products.
-
Consultation responses on the future reimbursement status of medicinal products for cardiovascular diseases
| 21 November 2008 |
The Reimbursement Committee’s additional recommendation concerning the future reimbursement status of medicinal products for cardiovascular diseases in ATC groups C02, C03, C07, C08 and C09 (antihypertensives) was submitted for consultation with 19 September 2008 as the consultation deadline